The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
The drug is also intended for the treatment of glioblastoma multiforme
When used alongside rehabilitative exercise, this device may offer benefit to those who have lost function in their upper limbs due to ischemic stroke
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
This multi-centre study (sites in the US and Europe) comprising about 387 patients is likely to be completed in about 36 months and the topline result is expected by the end of 2024
Subscribe To Our Newsletter & Stay Updated
